RxDoctor Payments Data

Yuly Juarez-Woodworth

Nurse Practitioner · Burleson, TXNPI 1831609411

Payments from drug & device makers

$3,351in general payments, 2019–2025

Across 190 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$552
  • Novo Nordisk$467
  • AstraZeneca$273
  • Bayer$229
  • Lilly USA, LLC$220
  • Boehringer Ingelheim$204
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,351100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,351 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$97,298
JardianceEmpagliflozin42$67,396
EliquisApixaban39$56,284
MounjaroTirzepatide26$38,065
TrulicityDulaglutide11$27,260
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$24,076
Tresiba Flextouch U-200Insulin Degludec30$20,981
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,507
VraylarCariprazine Hcl11$18,187
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,541
Gabapentin111$2,056
Atorvastatin Calcium286$1,930
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,757
Memantine Hcl38$1,211
Albuterol Sulfate HfaAlbuterol Sulfate57$1,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$467$97,29868 claims
Boehringer IngelheimJardiance$204$67,39642 claims
Lilly USA, LLCMounjaro, Trulicity$220$65,32537 claims
PfizerEliquis$143$56,28439 claims
AstraZenecaBreztri Aerosphere$273$24,07616 claims
AbbVieVraylar$552$18,18711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Burleson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →